Will Cannabis Ever Be Federally Legal? The 2026 Reality

TL;DR

For fifty years the answer was simple: no, and not close. As of 2026 it is genuinely split. In April 2026, a federal rule moved marijuana handled under state medical licenses — and FDA-approved marijuana drugs — from Schedule I to Schedule III. Adult-use cannabis remains Schedule I, as illegal federally as it has been since 1970, and the broader case that would move all marijuana is still pending with no decision date. Rescheduling is not legalization — but it is the first crack in the wall, and it happened on the medical side first.

How we got here: the timeline

• 1970: the Controlled Substances Act places marijuana in Schedule I — "high abuse potential, no accepted medical use" — where it stays untouched for over fifty years.
• October 2022: President Biden directs the Department of Health and Human Services and the DEA to review marijuana's scheduling.
• August 2023: after its scientific review, HHS formally recommends moving marijuana to Schedule III.
• May 2024: the DEA publishes a proposed rule to do exactly that, opening the formal rulemaking process — hearings, comments, and years of procedure.
• December 18, 2025: President Trump signs an executive order directing the Attorney General to expedite the stalled rescheduling process.
• April 28, 2026: the Justice Department's partial final rule takes effect. FDA-approved marijuana products and marijuana under qualifying state medical licenses move to Schedule III immediately; the question of everything else goes into an expedited hearing process.
• October 30, 2026: the DEA begins issuing federal registrations to state-licensed medical dispensaries — more than 900 across seven states in the first announcement.

What the April 2026 rule actually did

Schedule III is the category for substances with accepted medical use and moderate-to-low dependence potential — ketamine and anabolic steroids live there. Moving state-licensed medical marijuana into it means the federal government now formally accepts that this cannabis has medical use, which is a sentence that could not be written before 2026. Practical consequences followed: medical licensees can seek DEA registration, and the punitive Section 280E tax rule — which barred ordinary business deductions — no longer applies to the covered medical activities.

Just as important is what the rule did not do:

• It did not legalize anything. Schedule III substances are still controlled substances; the rule created a federal registration path for medical operators, not open permission.
• It did not touch adult-use cannabis. Recreational marijuana — including every legal California recreational sale — remains Schedule I under federal law.
• It did not authorize interstate commerce, override state licensing, or turn a state medical recommendation into a federal prescription.
• A state license alone is not federal authorization — medical operators must separately register with the DEA.

What is still pending

The broader question — moving all marijuana to Schedule III, including adult-use — is in a separate administrative proceeding that has been running since the 2024 proposal. As of this writing it sits in the hearing process: reply briefs were due November 5, 2026, after which the administrative judge may issue a recommendation, and the DEA would still have to issue a final rule. No date has been announced for any of that. It could conclude in a broader Schedule III rule; it could also stall the way the process stalled before.

And even a complete move to Schedule III would not be "federal legalization" in the way most people mean it. True legalization — cannabis treated like alcohol, removed from the Controlled Substances Act entirely — is called descheduling, and only Congress can do it. Bills to deschedule are introduced regularly and have passed one chamber before, but none has become law. That remains the final door, and it is a legislative one, not an administrative one.

What this means if you're a California consumer

Day to day, honestly, very little changes at the register. California's state system was already the law you actually live under, and it still is. The shifts to watch are structural: medical operators gaining federal registration and tax relief strengthens the medical side of the industry; research into cannabis becomes easier under Schedule III; and the split itself — medical federally acknowledged, recreational federally banned — is unstable by nature. Split systems tend to resolve in one direction or the other. Our travel guide covers what the federal split means when you move around with cannabis, which is where it touches consumers most directly.

Our perspective

Will cannabis ever be federally legal? The fifty-year answer was "eventually, maybe." The 2026 answer is more interesting: the federal government has already conceded the core factual claim — that cannabis has accepted medical use — and built a registration system for it. Legalization for adult use is still not here, still needs either a finished broader rule plus more, or an act of Congress, and anyone promising you a date is selling something. But the direction of travel is now set by the government's own actions rather than advocates' hopes. We run a state-licensed business inside that reality, and we will take accurate-and-incremental over soon-and-wrong every time.

FAQ

Is cannabis federally legal now?

No. As of late 2026, marijuana under state medical licenses and FDA-approved marijuana drugs sit in Schedule III — regulated, registrable, federally acknowledged as medical — while adult-use cannabis remains in Schedule I and illegal under federal law. Neither category is "legal" the way alcohol is legal.

What is the difference between Schedule I and Schedule III?

Schedule I means high abuse potential and no accepted medical use, with the heaviest federal restrictions. Schedule III means accepted medical use and lower dependence potential; substances there can be handled by federally registered parties and are not subject to the Section 280E tax penalty. The 2026 move was the federal government's first formal acceptance of medical use.

Does Schedule III mean I can travel with medical cannabis?

No. The rule created a registration framework for medical businesses; it did not give patients federal transport rights. TSA's position and state-by-state possession law still govern travel, as our travel guide explains.

What would full federal legalization require?

Descheduling — removing cannabis from the Controlled Substances Act entirely — which requires an act of Congress. Rescheduling through the DEA process can move cannabis between schedules but cannot remove it from the Act.

When will the broader rescheduling case be decided?

No date has been announced. The hearing process took reply briefs in November 2026; a judge's recommendation and a final DEA rule would follow, on the government's schedule. It is pending, not imminent — and not dead, either.

Sources

• American Bar Association. Federal Cannabis Rescheduling: Status Update (October 26, 2026) — the April 28, 2026 partial final rule, Schedule III scope, DEA registration requirement, and 280E consequences.
• Ohio State University Moritz College of Law, Drug Enforcement and Policy Center. Federal Marijuana Rescheduling: Process and Impact — the 2022–2026 timeline, the December 18, 2025 executive order, and the April 2026 Attorney General order.
• Federal Register. Schedules of Controlled Substances: Rescheduling of Marijuana — proposed rule, 89 FR 44597 (May 21, 2024).